Record Information
Version1.0
Creation Date2009-06-17 23:52:59 UTC
Update Date2026-04-14 20:23:49 UTC
Accession NumberCHEM000767
Identification
Common Name3-Iodo-2-propynyl butyl carbamate
ClassSmall Molecule
Description3-Iodo-2-propynyl butyl carbamate is a carbamate pesticide. Carbamate pesticides are derived from carbamic acid and kill insects in a similar fashion as organophosphate insecticides. They are widely used in homes, gardens and agriculture. The first carbamate, carbaryl, was introduced in 1956 and more of it has been used throughout the world than all other carbamates combined. Because of carbaryl's relatively low mammalian oral and dermal toxicity and broad control spectrum, it has had wide use in lawn and garden settings. Most of the carbamates are extremely toxic to Hymenoptera, and precautions must be taken to avoid exposure to foraging bees or parasitic wasps. Some of the carbamates are translocated within plants, making them an effective systemic treatment. (3)
Contaminant Sources
  • Clean Air Act Chemicals
  • Cosmetic Chemicals
  • HPV EPA Chemicals
  • STOFF IDENT Compounds
  • T3DB toxins
  • ToxCast & Tox21 Chemicals
Contaminant Type
  • Amine
  • Carbamate
  • Ester
  • Ether
  • Household Toxin
  • Organic Compound
  • Pesticide
  • Synthetic Compound
Chemical Structure
Thumb
Synonyms
ValueSource
3-Iodo-2-propyn-1-yl N-butylcarbamateChEBI
3-Iodoprop-2-ynyl butylcarbamateChEBI
Butyl-3-iodo-2-propynylcarbamateChEBI
IodocarbChEBI
IodocarbeChEBI
Iodopropynyl butylcarbamateChEBI
IPBCChEBI
Troysan KK-108aChEBI
Troysan polyphase anti-mildewChEBI
WoodlifeChEBI
3-Iodo-2-propyn-1-yl N-butylcarbamic acidGenerator
3-Iodoprop-2-ynyl butylcarbamic acidGenerator
Butyl-3-iodo-2-propynylcarbamic acidGenerator
Iodopropynyl butylcarbamic acidGenerator
3-Iodo-2-propynyl butylcarbamic acidGenerator
3-Iodo-2-propynyl butyl carbamic acidHMDB
3-IPBCHMDB
3-Iodo-2-propynyl-butylcarbamateHMDB
3-Iodo-2-propynylbutylcarbamateHMDB
3-iodo-2-Propynyl butylcarbamateChEBI
Chemical FormulaC8H12INO2
Average Molecular Mass281.091 g/mol
Monoisotopic Mass280.991 g/mol
CAS Registry Number55406-53-6
IUPAC Name3-iodoprop-2-yn-1-yl N-butylcarbamate
Traditional Nameiodopropynyl butylcarbamate
SMILESCCCCNC(=O)OCC#CI
InChI IdentifierInChI=1S/C8H12INO2/c1-2-3-6-10-8(11)12-7-4-5-9/h2-3,6-7H2,1H3,(H,10,11)
InChI KeyWYVVKGNFXHOCQV-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as carboximidic acids and derivatives. Carboximidic acids and derivatives are compounds containing a carboximidic group, with the general formula R-C(=NR1)OR2.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboximidic acids and derivatives
Sub ClassNot Available
Direct ParentCarboximidic acids and derivatives
Alternative Parents
Substituents
  • Haloacetylene or derivatives
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Carboximidic acid derivative
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Organoiodide
  • Organohalogen compound
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point66°C
Boiling PointNot Available
Solubility0.156 mg/mL at 20°C [JUERGENSEN,L et al. (2000)]
Predicted Properties
PropertyValueSource
Water Solubility0.12 g/LALOGPS
logP1.79ALOGPS
logP2.54ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)14ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area38.33 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity54.8 m³·mol⁻¹ChemAxon
Polarizability22.95 ųChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-08fr-8910000000-c2198b551efba8033141Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
LC-MS/MSLC-MS/MS Spectrum - 80V, Positivesplash10-03di-0900000000-b4d628d7dbd856cc520bSpectrum
LC-MS/MSLC-MS/MS Spectrum - 55V, Positivesplash10-03di-0900000000-e30fba30f8716fb5e9b5Spectrum
LC-MS/MSLC-MS/MS Spectrum - 35V, Positivesplash10-06s9-0930000000-dc7530cdc80507d195e4Spectrum
LC-MS/MSLC-MS/MS Spectrum - 55V, Positivesplash10-08g0-0920000000-ba057bb29bce4057c5a5Spectrum
LC-MS/MSLC-MS/MS Spectrum - 15V, Positivesplash10-03di-1920000000-a0395470a4adb5de5c77Spectrum
LC-MS/MSLC-MS/MS Spectrum - 35V, Positivesplash10-06s9-0930000000-8bd885f11b9544b3b25fSpectrum
LC-MS/MSLC-MS/MS Spectrum - 75V, Positivesplash10-03di-0900000000-5a59f90422bd99325496Spectrum
LC-MS/MSLC-MS/MS Spectrum - 90V, Positivesplash10-03di-0900000000-357e5a9da968087b7ff6Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-03di-0900000000-26ce5480f49bf180fed8Spectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Positivesplash10-03di-0900000000-4907115190dc317431e4Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-03di-0900000000-d2e28e17ee9d97baa699Spectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Positivesplash10-03di-0900000000-8ba604109cfddf6a4311Spectrum
LC-MS/MSLC-MS/MS Spectrum - 50V, Positivesplash10-03di-0900000000-932641616ba3ea78adb8Spectrum
LC-MS/MSLC-MS/MS Spectrum - 10V, Positivesplash10-03di-0930000000-431527f49af43b5a9238Spectrum
LC-MS/MSLC-MS/MS Spectrum - 40V, Positivesplash10-03di-0900000000-83863c4f3fbb9266f126Spectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Positivesplash10-03di-0900000000-c48f613fee6a7ea02ee1Spectrum
LC-MS/MSLC-MS/MS Spectrum - 75V, Positivesplash10-03di-0900000000-f81baee3a42d1c2be99aSpectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-03di-0900000000-0e4ab8bd9f070a9bd117Spectrum
LC-MS/MSLC-MS/MS Spectrum - 35V, Positivesplash10-06s9-0930000000-f85922bd3ab9109a6fc5Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0089-9570000000-0b591a043a5ababff9e7Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-05fr-9210000000-7563a4db509feaa37219Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-0a4l-9000000000-2bbe61eb999d8169ab91Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0002-9130000000-053d97dcb301e23822a6Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-0007-9120000000-75857c9eb9c5f50e1b71Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-052f-9220000000-b2456c3774d6442aac9cSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
Toxicity Profile
Route of ExposureInhalation (2) ; oral (2); dermal (2)
Mechanism of Toxicity3-Iodo-2-propynyl butyl carbamate is a cholinesterase or acetylcholinesterase (AChE) inhibitor. Carbamates form unstable complexes with chlolinesterases by carbamoylation of the active sites of the enzymes. This inhibition is reversible. A cholinesterase inhibitor suppresses the action of acetylcholine esterase. Because of its essential function, chemicals that interfere with the action of acetylcholine esterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop.
MetabolismThe carbamates are hydrolyzed enzymatically by the liver; degradation products are excreted by the kidneys and the liver. (2)
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Uses/Sources3-Iodo-2-propynyl butyl carbamate is widely used as an insecticide or pesticide in homes, gardens and agricultural applications. It is a synthetic compound.
Minimum Risk LevelNot Available
Health EffectsAcute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Chronically high (>10 years) exposure leads to neuropsychological consequences including disturbances in perception and visuo-motor processing (1).
SymptomsAs with organophosphates, the signs and symptoms are based on excessive cholinergic stimulation. Unlike organophosphate poisoning, carbamate poisonings tend to be of shorter duration because the inhibition of nervous tissue acetylcholinesterase is reversible, and carbamates are more rapidly metabolized. Muscle weakness, dizziness, sweating and slight body discomfort are commonly reported early symptoms. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Contraction of the pupils with blurred vision, incoordination, muscle twitching and slurred speech have been reported. (3)
TreatmentIf the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.
Concentrations
Not Available
DrugBank IDNot Available
HMDB IDHMDB0246958
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkIodopropynyl_butylcarbamate
Chemspider ID55933
ChEBI ID83279
PubChem Compound ID62097
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=11011936
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=12022126
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=15377347
4. https://www.ncbi.nlm.nih.gov/pubmed/?term=16854476
5. https://www.ncbi.nlm.nih.gov/pubmed/?term=23514087
6. https://www.ncbi.nlm.nih.gov/pubmed/?term=23869727
7. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26.